v3.26.3
Share-Based Compensation Plan (Tables)
9 Months Ended
Sep. 30, 2026
Share-Based Compensation Plans  
Schedule of stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Weighted

​

Average

​

Aggregate

​

​

​

​

Average

​

Remaining

​

Intrinsic

​

​

​

​

Exercise

​

Contractual

​

Value*

Stock Options

  ​ ​ ​

Shares

  ​ ​ ​

Price

  ​ ​ ​

Term (In Years)

  ​ ​ ​

(In Thousands)

Outstanding at January 1, 2026

 

512,705

​

$

26.15

 

  ​

 

​

  ​

Granted

 

—

​

​

—

 

  ​

 

​

  ​

Exercised

 

(176,730)

​

​

26.12

 

  ​

 

​

  ​

Forfeited or expired

 

(9,090)

​

​

29.24

 

  ​

 

​

  ​

Outstanding at September 30, 2026

 

326,885

​

$

26.07

 

5.0

​

$

7,302

Exercisable at September 30, 2026

 

252,989

​

$

25.87

 

4.6

​

$

5,702

​

*The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of our Company’s common stock on September 30, 2026 of $48.41 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.

Schedule of restricted stock award activity

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Weighted

​

Average

​

​

Aggregate

​

​

Shares of

​

Average

​

Remaining

​

​

Intrinsic

​

​

Restricted

​

Grant Date

​

Contractual

​

​

Value*

Restricted Stock

​

Stock

​

Fair Value

​

Term (In Years)

​

​

(In Thousands)

Non-vested - January 1, 2026

 

120,539

​

$

31.06

​

​

​

​

​

​

Granted

 

47,846

​

 

45.58

​

 

​

​

 

​

Vested

 

(41,834)

​

 

30.86

​

 

​

​

 

​

Forfeited

 

(6,036)

​

 

34.50

​

 

​

​

 

​

Non-vested - September 30, 2026

 

120,515

​

$

30.90

​

3.9

​

​

$

5,834

​

*The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of our Company’s common stock on September 30, 2026 of $48.41 multiplied by the number of non-vested restricted shares outstanding.